Tempest Announces $4.6 Million Registered Direct Offering of Common Stock. BRISBANE, Calif., June 11, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage ...

The Tempest, The Globe, review: Three Lions, blow-up lobsters and Prospero in a pair of budgie smugglers Sean Holmes's modish adaptation has gimmicks aplenty, but somehow works ...

BRISBANE, Calif., April 09, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class i targeted and immune-mediated ...

BRISBANE, Calif., June 11, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company with a pipeline of first-in-class1 targeted and immune ...

BRISBANE, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class 1 targeted and immune-mediated ...

Builds on clearances already received by FDA and EMAChina has the largest population of patients with hepatocellular carcinoma in the world ...

In what must surely be a first, Ferdy Roberts, as Shakespeare’s marooned wizard Prospero, spends most of this lucid, playful production wearing just loafers and bright yellow budgie-smuggler swimming ...

Prospero begins proceedings by commanding his daughter, Miranda, to “Pluck my magic garment from me” – in Sean Holmes’ latest production at Shakespeare’s Globe, that magic garment is a purple poncho ...

Detailed price information for Tempest Therapeutics Inc (TPST-Q) from The Globe and Mail including charting and trades.

BRISBANE, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-classi targeted and immune-mediated ...